NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.

Private
HuzhouHealthcare & Life Scienceshttps://www.yaodou.cn/

Last Round

Debt

Jan 27, 2026

Total Funding Raised

$69.18M

Company Overview

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. is a pharmaceutical e-commerce and technology services company that operates the Yaodou platform, focusing on pharmaceutical distribution in the out-of-hospital segment in China.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, E-commerce, Supply Chain, Retail Technology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

pharmaceutical distributionpharmaceutical e-commerceB2B procurementsupply chain managementpharma marketplaceout-of-hospital carechronic disease managementpharmacy franchisedigital pharmacyS2B2Ccross-border pharmae-healthhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 27, 2026
Series DMay 22, 2024
Series CApr 14, 2021
Series BJul 9, 2020
Series ASep 3, 2018

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Investors

Notable investors and investment history

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. investors
InvestorRounds
申万宏源证券资产管理有限公司Series B
Asian Development BankDebt

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHuzhou
Year Founded2014
Last FundingJan 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.